Premium intraocular lenses drive Q3 top-line for ophthalmic companies
This article was originally published in Clinica
Executive Summary
Advanced Medical Optics (AMO) continued to reap the rewards of its $1.3bn acquisition of refractive surgical company VISX (completed in May this year), with the latter contributing $47.7m to total third-quarter ophthalmic surgical revenues. Sales of laser vision correction (LVC) systems during this period were particularly robust, soaring 71% to $11.1m, compared with VISX's reported system sales in the third quarter last year, and revenues from LVC licensing fees rose 15% to $31.2m.